Notably, patients in cluster 1 exhibited the lowest prevalence but the most unfavorable risk profile already early in pregnancy and were characterized by elevated lipids in addition to hyperglycemia, as well as beta-cell dysfunction and particularly impaired insulin sensitivity. This evidence concerns the gene INS and Hyperglycemia.